Detalhe da pesquisa
1.
heredERA Breast Cancer: a phase III, randomized, open-label study evaluating the efficacy and safety of giredestrant plus the fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injection in patients with previously untreated HER2-positive, estrogen receptor-positive locally advanced or metastatic breast cancer.
BMC Cancer
; 24(1): 641, 2024 May 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-38789924
2.
A real-world study of the first use of palbociclib for the treatment of advanced breast cancer within the UK National Health Service as part of the novel Ibrance® Patient Program.
Br J Cancer
; 129(5): 852-860, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37468569
3.
Vaccine effectiveness against COVID-19 breakthrough infections in patients with cancer (UKCCEP): a population-based test-negative case-control study.
Lancet Oncol
; 23(6): 748-757, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35617989
4.
Enhanced axillary assessment using intradermally injected microbubbles and contrast-enhanced ultrasound (CEUS) before neoadjuvant systemic therapy (NACT) identifies axillary disease missed by conventional B-mode ultrasound that may be clinically relevant.
Breast Cancer Res Treat
; 185(2): 413-422, 2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-33029707
5.
The impact of Oncotype DX breast cancer assay results on clinical practice: a UK experience.
Breast Cancer Res Treat
; 180(3): 809-817, 2020 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-32170635
6.
Safe prescribing in cancer patients during the COVID-19 pandemic: A new initiative from the UK Cancer Coronavirus Project (UKCCP) team.
Int J Cancer
; 152(6): 1275-1277, 2023 03 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36454180
7.
Comparison of Circulating Tumor DNA Assays for Molecular Residual Disease Detection in Early-Stage Triple-Negative Breast Cancer.
Clin Cancer Res
; 30(4): 895-903, 2024 02 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38078899
8.
A population-scale temporal case-control evaluation of COVID-19 disease phenotype and related outcome rates in patients with cancer in England (UKCCP).
Sci Rep
; 13(1): 11327, 2023 07 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-37491478
9.
Association of SARS-CoV-2 Spike Protein Antibody Vaccine Response With Infection Severity in Patients With Cancer: A National COVID Cancer Cross-sectional Evaluation.
JAMA Oncol
; 9(2): 188-196, 2023 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36547970
10.
COVID-19: Third dose booster vaccine effectiveness against breakthrough coronavirus infection, hospitalisations and death in patients with cancer: A population-based study.
Eur J Cancer
; 175: 1-10, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36084618
11.
Palbociclib in combination with aromatase inhibitors in patients ≥ 75 years with oestrogen receptor-positive, human epidermal growth factor receptor 2 negative advanced breast cancer: A real-world multicentre UK study.
Breast
; 60: 199-205, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-34736090
12.
Fulvestrant Plus Vistusertib vs Fulvestrant Plus Everolimus vs Fulvestrant Alone for Women With Hormone Receptor-Positive Metastatic Breast Cancer: The MANTA Phase 2 Randomized Clinical Trial.
JAMA Oncol
; 5(11): 1556-1564, 2019 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31465093
13.
Impact of estrogen deprivation on gene expression profiles of normal postmenopausal breast tissue in vivo.
Cancer Epidemiol Biomarkers Prev
; 17(4): 855-63, 2008 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-18398027
14.
Bronchoalveolar carcinoma as an unsuspected cause for worsening shortness of breath in a patient with metastatic breast cancer.
BMJ Case Rep
; 20182018 Nov 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30413446
15.
Carboplatin in BRCA1/2-mutated and triple-negative breast cancer BRCAness subgroups: the TNT Trial.
Nat Med
; 24(5): 628-637, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29713086
16.
Comparison of the systemic and intratumoral effects of tamoxifen and the aromatase inhibitor vorozole in postmenopausal patients with primary breast cancer.
J Clin Oncol
; 20(4): 1026-35, 2002 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-11844826
17.
Antiproliferative Effect of Lapatinib in HER2-Positive and HER2-Negative/HER3-High Breast Cancer: Results of the Presurgical Randomized MAPLE Trial (CRUK E/06/039).
Clin Cancer Res
; 21(13): 2932-40, 2015 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25398453
18.
Effects of the aromatase inhibitor letrozole on normal breast epithelial cell proliferation and metabolic indices in postmenopausal women: a pilot study for breast cancer prevention.
Cancer Epidemiol Biomarkers Prev
; 11(7): 614-21, 2002 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-12101108
19.
Breast cancer.
Cancer Chemother Biol Response Modif
; 22: 545-61, 2005.
Artigo
em Inglês
| MEDLINE | ID: mdl-16110628
20.
Rechallenging with anthracyclines and taxanes in metastatic breast cancer.
Nat Rev Clin Oncol
; 7(10): 561-74, 2010 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-20808300